Search

everythinglearnresearchcommunity

for

Search:↓

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

Short Anagen Syndrome causes persistently short hair and increased shedding, usually improving after puberty.

A new topical solution safely reduces hair shedding by 38% on average by tightening a muscle in the scalp.

Some generic finasteride may be counterfeit, leading to less effectiveness and increased hair loss.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

Minoxidil treatment can reduce hair shedding, increase hair volume, and even change hair color in patients with loose anagen hair syndrome.

Etretinate therapy can cause hair loss by disrupting the hair growth cycle.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Telogen Effluvium causes more hair loss because hair moves to the resting phase too soon.

Different types of hair loss within Telogen Effluvium are caused by various disruptions in hair growth cycles.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

A simple wash test can help differentiate between two types of hair loss, and dermatoscopy should be used for further clarification.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

A simple method using the wash test and dermatoscopy can help differentiate between two hair loss conditions, androgenetic alopecia and chronic telogen effluvium.

A simple method using the wash test and dermatoscopy can help differentiate between two hair loss conditions, androgenetic alopecia and chronic telogen effluvium.

Healthy women tend to lose more hair in July and April, and the least in February.

New shampoo with tyramine hydrochloride reduces hair loss by making a small muscle in the hair follicle contract.

About 30% of women feel they lose too much hair, often starting before age 40, and most can't find a reason for it.

The new visual scale is a quick and effective way to measure hair loss in women.